About Biomatlante
Biomatlante is a company based in France founded in 1995 was acquired by Advanced Medical Solutions in December 2019.. Biomatlante has raised $5.1 million across 2 funding rounds from investors including Advanced Medical Solutions. Biomatlante offers products and services including MBCP®, In’Oss™, and EZ Cure™. Biomatlante operates in a competitive market with competitors including Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
- Headquarter Brittany, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomatlante Sas
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.1 M (USD)
in 2 rounds
-
Latest Funding Round
$286.77 K (USD), Grant
Jan 01, 2017
- Investors
-
Employee Count
Employee Count
-
Acquired by
Advanced Medical Solutions
(Dec 02, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomatlante
Biomatlante offers a comprehensive portfolio of products and services, including MBCP®, In’Oss™, and EZ Cure™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Material for bone regeneration in orthopedic surgeries
Injectable solution for enhancing bone repair
Membrane for guided bone regeneration in dental procedures
Funding Insights of Biomatlante
Biomatlante has successfully raised a total of $5.1M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $286.77 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $286,772
-
First Round
First Round
(28 Sep 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2017 | Amount | Grant - Biomatlante | Valuation |
investors |
|
| Sep, 2009 | Amount | Series A - Biomatlante | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biomatlante
Biomatlante has secured backing from 1 investor. Prominent investors backing the company include Advanced Medical Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wound care products and surgical dressings are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biomatlante
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biomatlante
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomatlante Comparisons
Competitors of Biomatlante
Biomatlante operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biomatlante
When was Biomatlante founded?
Biomatlante was founded in 1995 and raised its 1st funding round 14 years after it was founded.
Where is Biomatlante located?
Biomatlante is headquartered in France. It is registered at Brittany, France.
Is Biomatlante a funded company?
Biomatlante is a funded company, having raised a total of $5.1M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.1M, raised on Sep 28, 2009.
What does Biomatlante do?
Biomatlante was founded in 1995 in Brittany, France, focusing on biomaterials in the medical device sector. Synthetic bone graft technologies are provided for orthopedic, spine, dental, and sports medicine applications. Solutions include biphasic calcium phosphate products for reconstruction and traumatology, spine fusions in cervical and thoracolumbar regions, dental bone and soft tissue regeneration, and resorbable fixation systems like Osteotwin for sports injuries. MBCP technology emphasizes micromacroporosity and biphasic composition.
Who are the top competitors of Biomatlante?
Biomatlante's top competitors include EpiBone, Theradaptive and MiMedx Group.
What products or services does Biomatlante offer?
Biomatlante offers MBCP®, In’Oss™, and EZ Cure™.
Who are Biomatlante's investors?
Biomatlante has 1 investor. Key investors include Advanced Medical Solutions.